Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
50.10
-45.65
-91.12%
Share Warrants & Outstandings
Total Reserve
-6.44
31.86
-38.30
-120.21%
Shareholder's Funds
-1.99
83.71
-85.70
-102.38%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.09
0.00
8.09
0.00%
Secured Loans
5.10
0.00
5.10
0.00%
Unsecured Loans
2.99
0.00
2.99
0.00%
Deferred Tax Assets / Liabilities
-0.19
0.22
-0.41
-186.36%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.44
-0.44
-100.00%
Total Non-Current Liabilities
7.51
0.66
6.85
1,037.88%
Current Liabilities
Trade Payables
10.22
10.22
0.00
0.00%
Other Current Liabilities
2.24
3.30
-1.06
-32.12%
Short Term Borrowings
0.00
2.13
-2.13
-100.00%
Short Term Provisions
0.59
1.51
-0.92
-60.93%
Total Current Liabilities
13.04
17.15
-4.11
-23.97%
Total Liabilities
18.56
101.53
-82.97
-81.72%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.69
128.04
-110.35
-86.18%
Less: Accumulated Depreciation
9.72
60.06
-50.34
-83.82%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.97
67.99
-60.02
-88.28%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.25
-0.25
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
0.00
0.40
0.00%
Long Term Loans & Advances
0.18
0.78
-0.60
-76.92%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
8.56
69.02
-60.46
-87.60%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.31
24.50
-21.19
-86.49%
Sundry Debtors
1.28
1.49
-0.21
-14.09%
Cash and Bank
0.09
0.79
-0.70
-88.61%
Other Current Assets
0.00
5.68
-5.68
-100.00%
Short Term Loans and Advances
5.32
0.05
5.27
10,540.00%
Total Current Assets
10.00
32.51
-22.51
-69.24%
Net Current Assets (Including Current Investments)
-3.03
15.36
-18.39
-119.73%
Total Current Assets Excluding Current Investments
10.00
32.51
-22.51
-69.24%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18.56
101.53
-82.97
-81.72%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.32
2.13
5.19
243.66%
Book Value per share (adjusted)
-4.47
16.36
-20.83
-127.32%
Annual - Borrowings
Borrowings 7.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Annual - Investments
Investments 0.40 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
